CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 150 of 352 entries

View as:

Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema

Phase: N/A Priority: Normal

NCT ID: NCT02052141 Org: User:

Start: 03/20/14 End: 05/04/17 Due: 05/04/18

A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Phase: N/A Priority: Normal

NCT ID: NCT01047306 Org: User:

Start: 02/15/10 End: 07/10/13 Due: 07/10/14

Replagal Enzyme Replacement Therapy for Children With Fabry Disease

Phase: N/A Priority: Normal

NCT ID: NCT00084084 Org: User:

Start: 06/10/04 End: 06/15/11 Due: 06/15/12

A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

Phase: N/A Priority: Normal

NCT ID: NCT03283085 Org: User:

Start: 02/27/18 End: 12/13/23 Due: 12/13/24

A Study of Replagal in Treatment-naïve Adults With Fabry Disease

Phase: N/A Priority: Normal

NCT ID: NCT04840667 Org: User:

Start: 12/28/21 End: 12/16/22 Due: 12/16/23

Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT00151892 Org: User:

Start: 04/08/05 End: 09/07/09 Due: 09/07/10

A Study of SHP655 (rADAMTS13) in Sickle Cell Disease

Phase: N/A Priority: Normal

NCT ID: NCT03997760 Org: User:

Start: 10/21/19 End: 10/26/22 Due: 10/26/23

Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01235338 Org: User:

Start: 10/28/10 End: 01/17/11 Due: 01/17/12

Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Phase: N/A Priority: Normal

NCT ID: NCT00411645 Org: User:

Start: 12/13/06 End: 05/23/09 Due: 05/23/10

THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone

Phase: N/A Priority: Normal

NCT ID: NCT03013166 Org: User:

Start: 09/01/16 End: 12/01/16 Due: 12/01/17

Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)

Phase: N/A Priority: Normal

NCT ID: NCT02386839 Org: User:

Start: 03/26/15 End: 09/28/21 Due: 09/28/22

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Phase: N/A Priority: Normal

NCT ID: NCT01106430 Org: User:

Start: 06/28/10 End: 07/19/12 Due: 07/19/13

Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

Phase: N/A Priority: Normal

NCT ID: NCT01352585 Org: User:

Start: 07/19/11 End: 09/19/13 Due: 09/19/14

Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal

NCT ID: NCT01274221 Org: User:

Start: 03/06/11 End: 05/04/11 Due: 05/04/12

Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)

Phase: N/A Priority: Normal

NCT ID: NCT01510028 Org: User:

Start: 02/02/12 End: 01/20/17 Due: 01/20/18

Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder

Phase: N/A Priority: Normal

NCT ID: NCT01291173 Org: User:

Start: 05/10/11 End: 01/30/12 Due: 01/30/13

Use of NPSP558 in the Treatment of Hypoparathyroidism

Phase: N/A Priority: Normal

NCT ID: NCT00732615 Org: User:

Start: 12/18/08 End: 09/28/11 Due: 09/28/12

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17

Phase: N/A Priority: Normal

NCT ID: NCT00784654 Org: User:

Start: 01/27/09 End: 10/26/11 Due: 10/26/12

Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)

Phase: N/A Priority: Normal

NCT ID: NCT00567723 Org: User:

Start: 04/25/06 End: 06/07/16 Due: 06/07/17

OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension

Phase: N/A Priority: Normal

NCT ID: NCT01642212 Org: User:

Start: 07/23/12 End: 10/30/14 Due: 10/30/15

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT02093663 Org: User:

Start: 12/12/14 End: 11/28/18 Due: 11/28/19

Long-term Effect of Lanthanum Carbonate on Bone

Phase: N/A Priority: Normal

NCT ID: NCT00557323 Org: User:

Start: 03/15/07 End: 08/31/10 Due: 08/31/11

A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)

Phase: N/A Priority: Normal

NCT ID: NCT00926185 Org: User:

Start: 08/03/09 End: 02/18/10 Due: 02/18/11

Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)

Phase: N/A Priority: Normal

NCT ID: NCT03566823 Org: User:

Start: 07/17/18 End: 08/18/20 Due: 08/18/21

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Phase: N/A Priority: Normal

NCT ID: NCT00097695 Org: User:

Start: 12/28/04 End: 07/17/06 Due: 07/17/07

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema	NCT02052141	Shire	user2@example.com	None	2014-03-20	2017-05-04	2018-05-04	-	-	2025-07-14
A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA)	NCT01047306	Shire	user2@example.com	None	2010-02-15	2013-07-10	2014-07-10	-	-	2025-07-14
Replagal Enzyme Replacement Therapy for Children With Fabry Disease	NCT00084084	Shire	user2@example.com	None	2004-06-10	2011-06-15	2012-06-15	-	-	2025-07-14
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)	NCT03283085	Shire	user2@example.com	None	2018-02-27	2023-12-13	2024-12-13	-	-	2025-07-14
A Study of Replagal in Treatment-naïve Adults With Fabry Disease	NCT04840667	Shire	user2@example.com	None	2021-12-28	2022-12-16	2023-12-16	-	-	2025-07-14
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis	NCT00151892	Shire	user2@example.com	None	2005-04-08	2009-09-07	2010-09-07	-	-	2025-07-14
A Study of SHP655 (rADAMTS13) in Sickle Cell Disease	NCT03997760	Shire	user2@example.com	None	2019-10-21	2022-10-26	2023-10-26	-	-	2025-07-14
Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers	NCT01235338	Shire	user2@example.com	None	2010-10-28	2011-01-17	2012-01-17	-	-	2025-07-14
Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients	NCT00411645	Shire	user2@example.com	None	2006-12-13	2009-05-23	2010-05-23	-	-	2025-07-14
THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone	NCT03013166	Shire	user2@example.com	None	2016-09-01	2016-12-01	2017-12-01	-	-	2025-07-14
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)	NCT02386839	Shire	user2@example.com	None	2015-03-26	2021-09-28	2022-09-28	-	-	2025-07-14
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate	NCT01106430	Shire	user2@example.com	None	2010-06-28	2012-07-19	2013-07-19	-	-	2025-07-14
Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®	NCT01352585	Shire	user2@example.com	None	2011-07-19	2013-09-19	2014-09-19	-	-	2025-07-14
Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)	NCT01274221	Shire	user2@example.com	None	2011-03-06	2011-05-04	2012-05-04	-	-	2025-07-14
Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)	NCT01510028	Shire	user2@example.com	None	2012-02-02	2017-01-20	2018-01-20	-	-	2025-07-14
Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder	NCT01291173	Shire	user2@example.com	None	2011-05-10	2012-01-30	2013-01-30	-	-	2025-07-14
Use of NPSP558 in the Treatment of Hypoparathyroidism	NCT00732615	Shire	user2@example.com	None	2008-12-18	2011-09-28	2012-09-28	-	-	2025-07-14
Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17	NCT00784654	Shire	user2@example.com	None	2009-01-27	2011-10-26	2012-10-26	-	-	2025-07-14
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)	NCT00567723	Shire	user2@example.com	None	2006-04-25	2016-06-07	2017-06-07	-	-	2025-07-14
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension	NCT01642212	Shire	user2@example.com	None	2012-07-23	2014-10-30	2015-10-30	-	-	2025-07-14
Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis	NCT02093663	Shire	user2@example.com	None	2014-12-12	2018-11-28	2019-11-28	-	-	2025-07-14
Long-term Effect of Lanthanum Carbonate on Bone	NCT00557323	Shire	user2@example.com	None	2007-03-15	2010-08-31	2011-08-31	-	-	2025-07-14
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)	NCT00926185	Shire	user2@example.com	None	2009-08-03	2010-02-18	2011-02-18	-	-	2025-07-14
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)	NCT03566823	Shire	user2@example.com	None	2018-07-17	2020-08-18	2021-08-18	-	-	2025-07-14
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema	NCT00097695	Shire	user2@example.com	None	2004-12-28	2006-07-17	2007-07-17	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance